Research & development

The company has a strong R&D group which is very experienced in process discovery and development and we take on projects at all stages of the product development cycle. Our target is to develop 8-10 new products per year.

R&D Strategy

Research and Development efforts are geared towards obtaining the highest levels of customer satisfaction. This means that we strive to offer our customers all they need to have a prominent position in the market and to succeed in their new launches. Their success is our success and the people of Medichem are aware of that. In Research & Development terms this means that we need to be able to provide validated Pilot Plant quantities in the right time together with a full technical package that includes reference standards with full categorization and analytical methods.

To obtain that goal we have a flexible structure that allows us to allocate the necessary resources to each project.

We rely on a group of highly skilled chemists with many years of experience in process chemistry and analytical method development and a strong desire for success.

Each part of the chain receives the same care, from project selection to validation, from process optimization to analytical method development, from route selection to environmental care, from safety to impurity profiling.

Our laboratories

We have three state-of-the-art laboratories occupying a total area of 820 m2.

They are fully equipped with standard equipment and also with automated equipment for performing parallel chemistry and optimization. Each laboratory has its own analytical section for analytical method development.

Two of the labs are in Spain, one is at the Celrà Industrial Park factory (province of Girona), the other is at the Barcelona Science Park. The third one is at our new plant in Malta.

These three laboratories give us research capacity to cover our present R&D needs and are prepared for expansion to cope with the company’s future requirements.

Scientific Partners

We have established a number of successful collaborations with universities and public centers for scientific consultancy and for producing reference standards. We see this as a dynamic process in our constant quest for new techniques, processes and facilities and for teaching staff distinguished by their excellence in their specialist fields.

We also work closely with some world-class companies offering highly specialized techniques. In these cases the development is carried out under the close supervision of our R&D Project Leaders who are responsible for continuing the work in-house and for the supervision of the scale-up.

R&D Lines

Products for the following therapeutic categories are currently available or in the pipeline:

• Antiacne agents
• Antiarrhythmics
• Antiasthmatics
• Anticonvulsants
• Antidepressants
• Antidiabetics
• Antifungals
• Antiglaucomas
• Antihistaminics
• Antihyperlipoproteinemics / Antilipemics
• Antihyperparathyroid
• Antihypertensives
• Antiosteoporotics
• Antiprostatics
• Antipsychotics
• Antiseptics/Disinfectants
• Antispasmodics
• Antithrombotics
• Antiulceratives
• Antivirals
• Anxiolytics
• Hypnotics
• Nootropics
• Skeletal muscle relaxants